Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2021 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Johnson City, US HQ |
Employees | Employees 1633% increase | Employees 7 |
Funding | ||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 5m |

Bryleos (also known as BioNADrx Holdings) is a clinical stage therapeutics company.
View company